Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriserede fysioterapeuter FysioDanmark Maribo ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.5% 1.2% 1.6% 2.9% 1.9% 1.6% 7.6% 7.6%   Credit score (0-100)   79 82 74 57 70 74 32 32   Credit rating   A A A BBB A A BB BB   Credit limit (kDKK)   12.6 35.9 3.2 0.0 0.6 7.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,162 2,661 2,646 2,426 2,192 2,738 0.0 0.0   EBITDA   756 727 299 30.0 367 689 0.0 0.0   EBIT   561 527 113 -134 250 598 0.0 0.0   Pre-tax profit (PTP)   554.5 523.0 120.5 -127.3 257.3 598.6 0.0 0.0   Net earnings   431.5 406.9 93.7 -100.3 200.7 463.7 0.0 0.0   Pre-tax profit without non-rec. items   554 523 120 -127 257 599 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   271 190 187 82.5 41.4 138 0.0 0.0   Shareholders equity total   1,318 1,125 1,218 1,098 1,299 1,713 1,263 1,263   Interest-bearing liabilities   9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,003 1,616 1,912 1,490 1,623 2,302 1,263 1,263   Net Debt   -471 -87.6 -299 -53.2 -381 -1,007 -1,146 -1,146     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,162 2,661 2,646 2,426 2,192 2,738 0.0 0.0   Gross profit growth   6.1% -15.8% -0.6% -8.3% -9.6% 24.9% -100.0% 0.0%   Employees   6 5 7 6 5 5 0 0   Employee growth %   0.0% -16.7% 40.0% -14.3% -16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,003 1,616 1,912 1,490 1,623 2,302 1,263 1,263   Balance sheet change%   8.8% -19.3% 18.4% -22.1% 8.9% 41.9% -45.2% 0.0%   Added value   755.8 726.9 298.5 30.0 413.2 689.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -349 -370 -277 -356 -234 -53 -138 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.7% 19.8% 4.3% -5.5% 11.4% 21.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   29.4% 29.2% 6.9% -7.2% 16.7% 31.0% 0.0% 0.0%   ROI %   41.4% 40.6% 9.2% -9.7% 21.2% 39.8% 0.0% 0.0%   ROE %   35.9% 33.3% 8.0% -8.7% 16.7% 30.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   65.8% 69.6% 63.7% 73.7% 80.0% 74.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -62.3% -12.1% -100.2% -177.6% -103.9% -146.1% 0.0% 0.0%   Gearing %   0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.2% 100.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 2.0 2.4 2.7 4.2 3.3 0.0 0.0   Current Ratio   1.6 2.1 2.5 2.7 4.3 3.3 0.0 0.0   Cash and cash equivalent   480.8 87.6 299.0 53.2 381.1 1,007.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   391.5 443.1 737.0 640.4 963.9 1,326.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   126 145 43 5 83 138 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   126 145 43 5 73 138 0 0   EBIT / employee   93 105 16 -22 50 120 0 0   Net earnings / employee   72 81 13 -17 40 93 0 0